{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T17:36:32Z","timestamp":1789061792908,"version":"build-2803163510"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2018,9,19]],"date-time":"2018-09-19T00:00:00Z","timestamp":1537315200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Gastroenterol"],"published-print":{"date-parts":[[2019,3]]},"DOI":"10.1007\/s00535-018-1509-4","type":"journal-article","created":{"date-parts":[[2018,9,19]],"date-time":"2018-09-19T12:18:02Z","timestamp":1537359482000},"page":"261-270","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":40,"title":["The role of small intestinal bacterial overgrowth in cystic fibrosis: a randomized case-controlled clinical trial with rifaximin"],"prefix":"10.1007","volume":"54","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6424-079X","authenticated-orcid":false,"given":"Manuele","family":"Furnari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra","family":"De Alessandri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federico","family":"Cresta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Haupt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Bassi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Calvi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riccardo","family":"Haupt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giorgia","family":"Bodini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iftikhar","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Bagnasco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edoardo Giovanni","family":"Giannini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosaria","family":"Casciaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,9,19]]},"reference":[{"key":"1509_CR1","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/j.ccm.2007.02.011","volume":"28","author":"SD Strausbaugh","year":"2007","unstructured":"Strausbaugh SD, Davis PB. Cystic fibrosis: a review of epidemiology and pathobiology. Clin Chest Med. 2007;28:279\u201388.","journal-title":"Clin Chest Med"},{"issue":"530\u2013535","key":"1509_CR2","first-page":"e1","volume":"162","author":"EH Yen","year":"2013","unstructured":"Yen EH, Quinton MS, Borowitz D. Better nutritional status in early childhood is associated with improved clinical outcomes and survival in patients with cystic fibrosis. J Pediatr. 2013;162(530\u2013535):e1.","journal-title":"J Pediatr"},{"key":"1509_CR3","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1111\/apt.12456","volume":"38","author":"E Grace","year":"2013","unstructured":"Grace E, Shaw C, Whelan K, et al. Review article: small intestinal bacterial overgrowth\u2014prevalence, clinical features, current and developing diagnostic test, and treatment. Aliment Pharmacol Ther. 2013;38:674\u201388.","journal-title":"Aliment Pharmacol Ther"},{"key":"1509_CR4","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1016\/0016-5085(88)90173-4","volume":"95","author":"P Kerlin","year":"1988","unstructured":"Kerlin P, Wong L. Breath hydrogen testing in bacterial overgrowth of the small intestine. Gastroenterology. 1988;95:982\u20138.","journal-title":"Gastroenterology"},{"key":"1509_CR5","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1111\/apt.12479","volume":"38","author":"SC Shah","year":"2013","unstructured":"Shah SC, Day LW, Somsouk M, et al. Meta-analysis: antibiotic therapy for small intestinal bacterial overgrowth. Aliment Pharmacol Ther. 2013;38:925\u201334.","journal-title":"Aliment Pharmacol Ther"},{"key":"1509_CR6","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1517\/13543780902780175","volume":"18","author":"M Pimentel","year":"2009","unstructured":"Pimentel M. Review of rifaximin as treatment for SIBO and IBS. Expert Opin Investig Drugs. 2009;18:349\u201358.","journal-title":"Expert Opin Investig Drugs"},{"key":"1509_CR7","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1111\/j.1365-2036.2010.04436.x","volume":"32","author":"M Furnari","year":"2010","unstructured":"Furnari M, Parodi A, Gemignani E, et al. Clinical trial: the combination of rifaximin with partially hydrolysed guar gum is more effective than rifaximin alone in eradicating small intestinal bacterial overgrowth. Aliment Pharmacol Ther. 2010;32:1000\u20136.","journal-title":"Aliment Pharmacol Ther"},{"key":"1509_CR8","doi-asserted-by":"publisher","first-page":"G1032","DOI":"10.1152\/ajpgi.00473.2003","volume":"286","author":"O Norkina","year":"2004","unstructured":"Norkina O, Kaur S, Ziemer D, et al. Inflammation of the cystic fibrosis mouse small intestine. Am J Physiol Gastrointest Liver Physiol. 2004;286:G1032\u201341.","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"1509_CR9","doi-asserted-by":"publisher","first-page":"G1050","DOI":"10.1152\/ajpgi.00393.2003","volume":"286","author":"LL Clarke","year":"2004","unstructured":"Clarke LL, Gaweins LR, Bradford EM, et al. Abnormal paneth cell granule dissolution and compromised resistance to bacterial colonization in the intestine of CF mice. Am J Physiol Gastrointest Liver Physiol. 2004;286:G1050\u20138.","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"1509_CR10","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1097\/MPG.0b013e318290d112","volume":"57","author":"AJ Rovner","year":"2013","unstructured":"Rovner AJ, Schall JI, Mondick JT, et al. Delayed small bowel transit in children with cystic fibrosis and pancreatic insufficiency. J Pediatr Gastroenterol Nutr. 2013;57:81\u20134.","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"1509_CR11","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1097\/01.mpg.0000178439.64675.8d","volume":"41","author":"D Borowitz","year":"2005","unstructured":"Borowitz D, Durie PR, Clarke LL. Gastrointestinal outcomes and confounders in cystic fibrosis. J Pediatr Gastroenterol Nutr. 2005;41:273\u201385.","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"1509_CR12","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1046\/j.1365-2036.1996.d01-506.x","volume":"10","author":"SJ Lewis","year":"1996","unstructured":"Lewis SJ, Franco S, Young G, et al. Altered bowel function and duodenal bacterial overgrowth in patients treated with omeprazole. Aliment Pharmacol Ther. 1996;10:557\u201361.","journal-title":"Aliment Pharmacol Ther"},{"key":"1509_CR13","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1002\/ppul.21138","volume":"45","author":"B Weiss","year":"2010","unstructured":"Weiss B, Bujanover Y, Yahav Y, et al. Probiotic supplementation affects pulmonary exacerbation in patients with cystic fibrosis: a pilot study. Pediatr Pulmonol. 2010;45:536\u201340.","journal-title":"Pediatr Pulmonol"},{"key":"1509_CR14","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1097\/MPG.0b013e31802c0ceb","volume":"44","author":"JL Fridge","year":"2007","unstructured":"Fridge JL, Conrad C, Gerson L, et al. Risk factors for small bowel bacterial overgrowth in cystic fibrosis. J Pediatr Gastroenterol Nutr. 2007;44:212\u20138.","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"1509_CR15","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1046\/j.1440-1754.1998.00159.x","volume":"34","author":"PJ Lewindon","year":"1998","unstructured":"Lewindon PJ, Robb TA, Moore DJ, et al. Bowel dysfunction in cystic fibrosis: importance of breath testing. J Paediatr Child Health. 1998;34:79\u201382.","journal-title":"J Paediatr Child Health"},{"key":"1509_CR16","first-page":"631","volume":"56","author":"A Lisowska","year":"2009","unstructured":"Lisowska A, W\u00f2jtowicz J, Walkowiak J. Small intestinal bacterial overgrowth is frequent in cystic fibrosis: combined hydrogen and methane measurements are required for its detection. Acta Biochim Pol. 2009;56:631\u20134.","journal-title":"Acta Biochim Pol"},{"key":"1509_CR17","doi-asserted-by":"publisher","first-page":"S4","DOI":"10.1016\/j.jpeds.2008.05.005","volume":"153","author":"PM Farrell","year":"2008","unstructured":"Farrell PM, Rosenstein BJ, White TB, et al. Guidelines for diagnosis of cystic fibrosis in newborns through older adults: Cystic Fibrosis Foundation consensus report. J Pediatr. 2008;153:S4\u201314.","journal-title":"J Pediatr"},{"key":"1509_CR18","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1016\/j.jcf.2011.06.008","volume":"10","author":"A Lisowska","year":"2011","unstructured":"Lisowska A, Pogorzelski A, Oracz G, et al. Oral antibiotic therapy improves fat absorption in cystic fibrosis patients with small intestine bacterial overgrowth. J Cystic Fibros. 2011;10:418\u201321.","journal-title":"J Cystic Fibros"},{"key":"1509_CR19","doi-asserted-by":"publisher","first-page":"1964","DOI":"10.1016\/j.cgh.2013.09.055","volume":"12","author":"RJ Saad","year":"2014","unstructured":"Saad RJ, Chey WD. Breath testing for small intestinal bacterial overgrowth: maximizing test accuracy. Clin Gastrenterol Hepatol. 2014;12:1964\u201372.","journal-title":"Clin Gastrenterol Hepatol"},{"key":"1509_CR20","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1016\/j.semarthrit.2012.09.004","volume":"42","author":"L Gemignani","year":"2013","unstructured":"Gemignani L, Savarino V, Ghio M, et al. Lactulose breath test to assess oro-cecal transit delay and estimate esophageal dysmotility in scleroderma patients. Semin Arthritis Rheum. 2013;42:522\u20139.","journal-title":"Semin Arthritis Rheum"},{"key":"1509_CR21","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1067\/mpd.2002.124829","volume":"141","author":"S Beharry","year":"2002","unstructured":"Beharry S, Ellis L, Corey M, et al. How useful is fecal pancreatic elastase 1 as a marker of exocrine pancreatic disease? J Pediatr. 2002;141:84\u201390.","journal-title":"J Pediatr"},{"key":"1509_CR22","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1007\/s00535-006-1884-0","volume":"41","author":"S Naruse","year":"2006","unstructured":"Naruse S, Ishiguro H, Ko SBH, et al. Fecal pancreatic elastase: a reproducible marker for severe exocrine pancreatic insufficiency. J Gastroenterol. 2006;41:901\u20138.","journal-title":"J Gastroenterol"},{"key":"1509_CR23","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s12916-017-0783-y","volume":"15","author":"MR Struyvenberg","year":"2017","unstructured":"Struyvenberg MR, Martin CR, Freedman SD. Practical guide to exocrine pancreatic insufficiency\u2014breaking the myths. BMC Med. 2017;15:29.","journal-title":"BMC Med"},{"key":"1509_CR24","first-page":"1","volume":"29","author":"RE Karcher","year":"1999","unstructured":"Karcher RE, Truding RM, Stawick LE. Using a cut off of\u2009<\u200910\u00a0ppm for breath hydrogen testing: a review of five years\u2019 experience. Ann Clin Lab Sci. 1999;29:1\u20138.","journal-title":"Ann Clin Lab Sci"},{"key":"1509_CR25","doi-asserted-by":"publisher","first-page":"312","DOI":"10.5056\/jnm.2011.17.3.312","volume":"17","author":"UC Ghoshal","year":"2011","unstructured":"Ghoshal UC. How to interpret hydrogen breath tests. J Neurogastroenterol Motil. 2011;17:312\u20137.","journal-title":"J Neurogastroenterol Motil"},{"key":"1509_CR26","first-page":"6","volume":"25","author":"UC Ghoshal","year":"2006","unstructured":"Ghoshal UC, Ghoshal U, Das K, et al. Utility of hydrogen breath tests in diagnosis of small intestinal bacterial overgrowth in malabsorption syndrome and its relationship with oro-cecal transit time. Indian J Gastroenterol. 2006;25:6\u201310.","journal-title":"Indian J Gastroenterol"},{"key":"1509_CR27","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1056\/NEJM196101122640207","volume":"264","author":"GD Drummey","year":"1961","unstructured":"Drummey GD, Benson JA Jr, Jones CM. Microscopical examination of the stool for steatorrhea. N Engl J Med. 1961;264:85\u20137.","journal-title":"N Engl J Med"},{"key":"1509_CR28","doi-asserted-by":"publisher","first-page":"6","DOI":"10.3389\/fped.2014.00006","volume":"2","author":"T Pang","year":"2014","unstructured":"Pang T, Leach ST, Katz T, et al. Fecal biomarkers of intestinal health and disease in children. Front Pediatr. 2014;2:6.","journal-title":"Front Pediatr"},{"key":"1509_CR29","first-page":"13","volume":"45","author":"MF Rolland-Cacher\u00e0","year":"1991","unstructured":"Rolland-Cacher\u00e0 MF, Cole TJ, Semp\u00e8 M, et al. Body mass index variations: centiles from birth to 87 years. Eur J Clin Nutr. 1991;45:13\u201321.","journal-title":"Eur J Clin Nutr"},{"key":"1509_CR30","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1097\/00005176-198705000-00013","volume":"6","author":"Y Bujanover","year":"1987","unstructured":"Bujanover Y, Peled Y, Blau H, et al. Methane production in patients with cystic fibrosis. Pediatr Gastroenterol Nutr. 1987;6:377\u201380.","journal-title":"Pediatr Gastroenterol Nutr"},{"key":"1509_CR31","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1111\/nmo.12516","volume":"27","author":"A Erdogan","year":"2015","unstructured":"Erdogan A, Rao SS, Gulley D, et al. Small intestinal bacterial overgrowth: duodenal aspiration vs glucose breath test. Neurogastroenterol Motil. 2015;27:481\u20139.","journal-title":"Neurogastroenterol Motil"},{"key":"1509_CR32","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1136\/gut.2009.205476","volume":"60","author":"D Yu","year":"2010","unstructured":"Yu D, Cheeseman F, Vanner S. Combined oro-cecal scintigraphy and lactulose hydrogen breath testing demonstrate that breath test is detects oro-cecal transit, not small intestinal bacterial overgrowth in patients with IBS. Gut. 2010;60:334\u201340.","journal-title":"Gut"},{"key":"1509_CR33","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1111\/j.1572-0241.2008.01785.x","volume":"103","author":"JR Bratten","year":"2008","unstructured":"Bratten JR, Spanier J, Jones MP. Lactulose breath testing does not discriminate patients with irritable bowel syndrome from healthy controls. Am J Gastroenterol. 2008;103:958\u201363.","journal-title":"Am J Gastroenterol"},{"key":"1509_CR34","doi-asserted-by":"publisher","first-page":"1566","DOI":"10.1111\/j.1572-0241.2005.40795.x","volume":"100","author":"B Walters","year":"2005","unstructured":"Walters B, Vanner SJ. Detection of bacterial overgrowth in IBS using lactulose H2 breath test: comparison with 14C-D-xylose and healthy controls. Am J Gastroenterol. 2005;100:1566\u201370.","journal-title":"Am J Gastroenterol"},{"key":"1509_CR35","doi-asserted-by":"publisher","first-page":"1579","DOI":"10.1007\/s00330-014-3575-1","volume":"25","author":"E Savarino","year":"2015","unstructured":"Savarino E, Savarino V, Fox M, et al. Measurement of oro-caecal transit time by magnetic resonance imaging. Eur Radiol. 2015;25:1579\u201387.","journal-title":"Eur Radiol"},{"key":"1509_CR36","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1136\/adc.82.5.394","volume":"82","author":"RL Smyth","year":"2000","unstructured":"Smyth RL, Croft NM, O\u2019Hea U, et al. Intestinal inflammation in cystic fibrosis. Arch Dis Child. 2000;82:394\u20139.","journal-title":"Arch Dis Child"},{"key":"1509_CR37","doi-asserted-by":"publisher","first-page":"322","DOI":"10.3109\/00365513.2010.486869","volume":"70","author":"A Lisowska","year":"2010","unstructured":"Lisowska A, Madry E, Pogorzelski A, et al. Small intestinal bacterial overgrowth does not correspond to intestinal inflammation in cystic fibrosis. Scand J Clin Lab Investig. 2010;70:322\u20136.","journal-title":"Scand J Clin Lab Investig"},{"key":"1509_CR38","first-page":"1328","volume":"15","author":"C Fundar\u00f2","year":"2011","unstructured":"Fundar\u00f2 C, Fantacci C, Ansuini V, et al. Fecal calprotectin concentration in children affected by SIBO. Eur Rev Med Pharmacol Sci. 2011;15:1328\u201335.","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"1509_CR39","doi-asserted-by":"publisher","first-page":"615","DOI":"10.3109\/00365549609037970","volume":"28","author":"PO Stotzer","year":"1996","unstructured":"Stotzer PO, Blomberg L, Conway PL, et al. Probiotic treatment of small intestinal bacterial overgrowth by Lactobacillus fermentum. KLD Scand J infect Dis. 1996;28:615\u20139.","journal-title":"KLD Scand J infect Dis"},{"key":"1509_CR40","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.ccm.2015.10.003","volume":"37","author":"YJ Huang","year":"2016","unstructured":"Huang YJ, LiPuma JJ. The microbiome in cystic fibrosis. Clin Chest Med. 2016;37:59\u201367.","journal-title":"Clin Chest Med"},{"key":"1509_CR41","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/s12866-017-0968-8","volume":"17","author":"DG Burke","year":"2017","unstructured":"Burke DG, Fouhy F, Harrison MJ, et al. The altered gut microbiota in adults with cystic fibrosis. BMC Microbiol. 2017;17:58.","journal-title":"BMC Microbiol"},{"key":"1509_CR42","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1038\/nature11234","volume":"486","author":"Human Microbiome Project Consortium","year":"2012","unstructured":"Human Microbiome Project Consortium. Structure, function and diversity of the healthy human microbiome. Nature. 2012;486:207\u201314.","journal-title":"Nature"},{"key":"1509_CR43","first-page":"26050","volume":"26","author":"JM Rodr\u00edguez","year":"2015","unstructured":"Rodr\u00edguez JM, Murphy K, Stanton C, et al. The composition of the gut microbiota throughout life, with an emphasis on early life. Microb Ecol Health Dis. 2015;26:26050.","journal-title":"Microb Ecol Health Dis"},{"key":"1509_CR44","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1038\/nature11053","volume":"486","author":"T Yatsunenko","year":"2012","unstructured":"Yatsunenko T, Rey FE, Manary MJ, et al. Human gut microbiome viewed across age and geography. Nature. 2012;486:222\u20137.","journal-title":"Nature"},{"key":"1509_CR45","doi-asserted-by":"publisher","first-page":"3216","DOI":"10.1099\/mic.0.040618-0","volume":"156","author":"C Jernberg","year":"2010","unstructured":"Jernberg C, L\u00f6fmark S, Edlund C, Jansson JK. Long-term impacts of antibiotic exposure on the human intestinal microbiota. Microbiology. 2010;156:3216\u201323.","journal-title":"Microbiology"},{"key":"1509_CR46","doi-asserted-by":"publisher","first-page":"e280","DOI":"10.1371\/journal.pbio.0060280","volume":"6","author":"L Dethlefsen","year":"2008","unstructured":"Dethlefsen L, Huse S, Sogin ML, et al. The pervasive effects of an antibiotic on the human gut microbiota, as revealed by deep 16S rRNA sequencing. PLoS Biol. 2008;6:e280.","journal-title":"PLoS Biol"}],"container-title":["Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00535-018-1509-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00535-018-1509-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00535-018-1509-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,10]],"date-time":"2020-11-10T06:37:50Z","timestamp":1604990270000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00535-018-1509-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9,19]]},"references-count":46,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,3]]}},"alternative-id":["1509"],"URL":"https:\/\/doi.org\/10.1007\/s00535-018-1509-4","relation":{},"ISSN":["0944-1174","1435-5922"],"issn-type":[{"value":"0944-1174","type":"print"},{"value":"1435-5922","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,9,19]]},"assertion":[{"value":"12 June 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 September 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 September 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}